Champions Oncology
CSBR
CSBR
16 hedge funds and large institutions have $13.1M invested in Champions Oncology in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.7% less ownership
Funds ownership: 39.4% → 37.7% (-1.7%)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$127K | |
| 2 | +$83.8K | |
| 3 | +$53K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.7K |
Top Sellers
| 1 | -$576K | |
| 2 | -$127K | |
| 3 | -$99.5K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$39K |
| 5 |
PA
Perceptive Advisors
New York
|
-$17.8K |